Impact of low-dose rituximab on splenic B cells: Evidence for the shaving reaction

Transplant International

Volumn 23, Issue 1, 2010, Pages 116-117

  Taylor, Ronald P ^a   Lindorfer, Margaret A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; RITUXIMAB;

B LYMPHOCYTE; CANCER CELL; CHRONIC LYMPHATIC LEUKEMIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; B-LYMPHOCYTES; HUMANS; KIDNEY TRANSPLANTATION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTE DEPLETION; SPLEEN;

EID: 70949097907     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2009.00913.x     Document Type: Letter

References (9)

1. Toki D, Ishida H, Horita S, et al. Impact of low-dose rituximab on splenic B cells in ABO-incompatible renal transplant recipients. Transplant Int 2009 22 : 447.
2. Williams ME, Densmore JJ, Pawluczkowycz AW, et al. Thrice-weekly low-dose rituximab decreases CD20 loss via shaving and promotes enhanced targeting in chronic lymphocytic leukemia. J Immunol 2006 177 : 7435.
3. Kennedy AD, Beum PV, Solga MD, et al. Rituximab infusion promotes rapid complement depletion and acute CD20 loss in chronic lymphocytic leukemia. J Immunol 2004 172 : 3280.
4. Beum PV, Kennedy AD, Williams ME, Lindorfer MA, Taylor RP. The shaving reaction: Rituximab/CD20 complexes are removed from mantle cell lymphoma and chronic lymphocytic leukemia cells by THP-1 monocytes. J Immunol 2006 176 : 2600.
5. Schroff RW, Klein RA, Farrell MM, Stevenson HC. Enhancing effects of monocytes on modulation of a lymphocyte membrane antigen. J Immunol 1984 133 : 2270.
6. Joly E, Hudrisier D. What is trogocytosis and what is its purpose? Nat Immunol 2003 4 : 815.
7. Taylor RP, Lindorfer MA. Immunotherapeutic mechanisms of anti-CD20 monoclonal antibodies. Curr Opin Immunol 2008 20 : 444.
8. Li Y, Williams ME, Cousar JB, et al. Rituximab/CD20 complexes are shaved from Z138 mantle cell lymphoma cells in intravenous and subcutaneous SCID mouse models. J Immunol 2007 179 : 4263.
9. Beum PV, Mack DA, Pawluczkowycz AW, Lindorfer MA, Taylor RP. Binding of rituximab, trastuzumab, cetuximab, or mAb T101 to cancer cells promotes trogocytosis mediated by THP-1 cells and monocytes. J Immunol 2008 181 : 8120.